State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

Kennedy Jr., who has been tapped by Trump to lead the HHS, has been critical of Ozempic and other weight loss drugs.

Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...

What’s unique about GLP-1s—a.k.a. Ozempic, Monjauro, Wegovy, and Zepbound, among others—is that they target hormones, which ...

Two in three adults in England are overweight or obese - and 26 per cent of us have learned all we know about treatments like ...

Go on, give it a shot. Ozempic and other game-changing weight loss drugs are popular for a reason — but, nutrition experts ...